Rna replicon for improving gene expression and use thereof
US-2024417751-A1 · Dec 19, 2024 · US
US2023084966A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2023084966-A1 |
| Application number | US-202217823853-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 31, 2022 |
| Priority date | Sep 1, 2021 |
| Publication date | Mar 16, 2023 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A cofactor self-sufficient Escherichia coli and its construction method and application in the synthesis of L-glufosinate are provided. The present invention expresses a NADH kinase and key enzymes of the cofactor synthesis pathway in E. coli , and knocks out the genes of enzymes that catabolizes cofactor, and with the addition of co-metabolic intermediates during cell incubation, the intracellular NADP(H) concentration is increased by at least 50% and the catalytic activity of glutamate dehydrogenase by 2-fold, resulting in a significant increase in the spatiotemporal yield of the-glufosinate synthesis reaction.
Opening claim text (preview).
What is claimed is: 1 . A cofactor self-sufficient Escherichia coli , obtained by constructing methods as follows, (1) constructing expression vectors, transforming a NADH kinase gene, a glucose dehydrogenase gene, a glutamate dehydrogenase gene and a gene of NADP cofactor synthesis pathway into an Escherichia coli named E. coli BL21 (DE3), screening the correct transformants, and obtaining a glutamate dehydrogenase-glucose dehydrogenase-NADH kinase co-expressing gene engineering bacterium; said NADH kinase gene sequence is one of SEQ ID No. 1 to 5, said glucose dehydrogenase gene sequence is as shown in SEQ ID No. 6, said glutamate dehydrogenase gene sequence is as shown in SEQ ID No. 7, and said NADP cofactor synthesis pathway gene sequence is as shown in one of SEQ ID No. 8 to 10; (2) knocking out of any one or a combination of mazG, mudC, nadR genes in the genome of the co-expressing gene engineering bacterium to obtain said cofactor self-sufficient Escherichia coli. 2 . The cofactor self-sufficient Escherichia coli of claim 1 , wherein the sequence of said NADH kinase gene in step ( 1 ) is as shown in SEQ ID No. 3, and the sequence of said NADP cofactor synthesis pathway gene is as shown in SEQ ID No. 8. 3 . The cofactor self-sufficient Escherichia coli of claim 1 , wherein the mazG and nadR genes are knocked out in step ( 2 ). 4 . A method for constructing the cofactor self-sufficient Escherichia coli of claim 1 , comprising: (1) constructing expression vectors, transforming a NADH kinase gene, a glucose dehydrogenase gene, a glutamate dehydrogenase gene and a gene of the NADP cofactor synthesis pathway into E. coli BL21 (DE3), screening the correct transformants, and obtaining a glutamate dehydrogenase-glucose dehydrogenase-NADH kinase co-expressing gene engineering bacterium; said NADH kinase gene sequence is as one of SEQ ID No. 1 to 5, said glucose dehydrogenase gene sequence is as shown in SEQ ID No. 6, said glutamate dehydrogenase gene sequence is as shown in SEQ ID NO. 7, and said NADP cofactor synthesis pathway gene sequence is as shown in one of SEQ ID No. 8 to 10; (2) knocking out of any one or a combination of mazG, mudC, nadR in the genome of the co-expressing gene-engineering bacterium to obtain said cofactor self-sufficient Escherichia coli. 5 . The method as claimed in claim 4 , wherein the sequence of said NADH kinase gene in step ( 1 ) is as shown in SEQ ID No. 3 and the gene sequence of said NADP cofactor synthesis pathway is as shown in SEQ ID No. 8; the mazG and nadR genes are knocked out in step ( 2 ). 6 . An application of the cofactor self-sufficient Escherichia coli of claim 1 in the preparation of L-glufosinate by microbial fermentation. 7 . The application of claim 6 , wherein said application is: using the wet bacterial cells obtained by fermentation culture of said cofactor self-sufficient Escherichia coli or the enzyme solution extracted by ultrasonic crushing of said wet bacterial cells as the catalyst, using 2-carbonyl-4-(hydroxymethylphosphinyl)-butyric acid as the substrate, adding ammonium sulfate and glucose, using pH 7.5 buffer as the reaction medium to constitute the reaction system, and reacting at 35° C.˜40° C., 500˜600 rpm; after the reaction, the reaction solution is separated and purified to obtain L-glufosinate. 8 . The application of claim 7 , wherein in said reaction system, the amount of catalyst is 10˜50 g/L by total weight of wet bacterial cells, the initial concentration of substrate is 10˜500 mM, the amount of glucose addition is 12˜750 mM, and the amount of ammonium sulfate addition is 50 mM˜1.5M. 9 . The application of claim 7 , wherein in said reaction system, the amount of catalyst is 15 g/L by total weight of wet bacterial cells, the initial concentration of substrate is 200 mM, the amount of glucose addition is 250 mM, and the amount of ammonium sulfate addition is 300 mM.
Vectors or expression systems specially adapted for E. coli · CPC title
Glucose 1-dehydrogenase (NADP+) (1.1.1.119) · CPC title
NADH kinase (2.7.1.86) · CPC title
Genes encoding for enzymes or proenzymes · CPC title
Glutamate dehydrogenase (1.4.1.2) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.